Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials

Novartis shares rose after the drugmaker reported positive results in two late-stage trials from its new pill for the most common form of multiple sclerosis.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。